Ensysce Biosciences, Inc. Warrant 06/30/2026

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ENSCW and buy or sell other stocks, ETFs, and their options commission-free!

About ENSCW

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. 

CEO
D. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees
—
Employees—
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2003
Founded2003
Employees
—
Employees—

ENSCW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
23.21K
Average volume23.21K
High today
$0.0074
High today$0.0074
Low today
$0.0074
Low today$0.0074
Open price
$0.0074
Open price$0.0074
Volume
10.00K
Volume10.00K
52 Week high
$0.03
52 Week high$0.03
52 Week low
$0.0015
52 Week low$0.0015

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.